Indeed, the inhibition of RAD51 or of MRE11 promoted sensitization of SENS-CRC-SCs (Figure 1D) and of innRES-CRC-SCs (Figure 1E) to sublethal doses of prexasertib. Here, MRE11 is linked to colorectal carcinoma.